Favicon
Favicon

HIV Vaccines to be Tested at the Disease’s Epicenter

Date: October 9, 2012 By:

“An international research consortium plans to begin testing four new HIV vaccines in 2014 in a province of South Africa where the infection rate is among the highest in the world.

 

The unusual effort to test several vaccines nearly simultaneously reflects the difficulty of finding a way to prevent HIV infection, says Bruce Walker, a Harvard Medical Scho­­ol professor and one of the founding scientists of a new research center opening this month in Durban, in KwaZulu-Natal province, where the tests will occur.”

 

read the rest of the MIT Technology Review article

More News

Press Releases

Ragon faculty sheds light on intricate functions of Resident Tissue Macrophages (RTM’s) which extend beyond immune defense

The lab of the Ragon Institute faculty member Hernandez Moura Silva, PhD, recently published a review in Science Immunology regarding resident tissue macrophages (RTMs), shedding light on their multifaceted roles in organ health. 

‘Evolution of an Epidemic’ Returns — Taking Students Across South Africa to Learn the Real-World Impact of HIV and COVID-19

After three years off due to the COVID-19 pandemic, the Ragon-MIT course HST.434 returned this January to provide 24 students a once in a lifetime learning experience

Brandon DeKosky one of five MIT faculty members awarded by Cancer Grand Challenges

Ragon core member and MIT associate professor of chemical engineering Brandon DeKosky, PhD, was one of five MIT faculty members recently awarded $25 million to take on Cancer Grand Challenges.